100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached 4,6 TrustPilot
logo-home
Exam (elaborations)

NR 546 / NR546 Final Exam – Psychopharmacology for PMHNP: Complete 2025–2026 Study Guide with Real Exam Questions, Verified Answers & Expert Rationales

Rating
-
Sold
-
Pages
25
Grade
A+
Uploaded on
19-10-2025
Written in
2025/2026

NR 546 / NR546 Final Exam – Psychopharmacology for PMHNP: Complete 2025–2026 Study Guide with Real Exam Questions, Verified Answers & Expert Rationales Get fully prepared to ace your NR 546 / NR546 Psychopharmacology for PMHNP Final Exam with this most comprehensive, up-to-date 2025–2026 exam review. This expertly designed guide brings together real verified exam questions, accurate answers, and in-depth rationales that mirror the current NR 546 test blueprint. Developed for Psychiatric-Mental Health Nurse Practitioner (PMHNP) students, it covers every key topic— from antidepressants and antipsychotics to neurotransmitter systems, mood stabilizers, anxiolytics, and clinical psychopharmacology principle NR 546, NR546 Exam, NR 546 Psychopharmacology, PMHNP Exam Review, PMHNP Final Exam, NR546 2025 Study Guide, PMHNP Psychopharmacology Exam, NR 546 Final Answers, NR 546 Exam Questions, Psychopharmacology for PMHNP, Nursing Graduate Exam, PMHNP Study Guide 2025, NR546 Practice Questions, NR 546 Rationales, Nurse Practitioner Board Exam Prep, Psych Medications PMHNP, NR 546 Review 2026, PMHNP Comprehensive Final, NR 546 Verified Answers, NR546 Exam with Rationale, PMHNP Certification Prep, NR 546, NR546 Exam, NR 546 Psychopharmacology, PMHNP Exam Review, PMHNP Final Exam, NR546 2025 Study Guide, PMHNP Psychopharmacology Exam, NR 546 Final Answers, NR 546 Exam Questions, Psychopharmacology for PMHNP, Nursing Graduate Exam, PMHNP Study Guide 2025, NR546 Practice Questions, NR 546 Rationales, Nurse Practitioner Board Exam Prep, Psych Medications PMHNP, NR 546 Review 2026, PMHNP Comprehensive Final, NR 546 Verified Answers, NR546 Exam with Rationale, PMHNP Certification Prep, Chamberlain NR546 Exam, Nursing Pharmacology Review, Advanced Psychopharmacology, PMHNP Test Bank 2025, PMHNP Exam Success Guide, NR 546 First Attempt Pass, PMHNP Clinical Practice Exam, NR546 NCLEX-style Questions, Nursing Pharmacology Review, Advanced Psychopharmacology, PMHNP Test Bank 2025, PMHNP Exam Success Guide, NR 546 First Attempt Pass, PMHNP Clinical Practice Exam, NR546 NCLEX-style Questions

Show more Read less
Institution
NR 546 / NR546 Fi Nal
Course
NR 546 / NR546 Fi nal










Whoops! We can’t load your doc right now. Try again or contact support.

Written for

Institution
NR 546 / NR546 Fi nal
Course
NR 546 / NR546 Fi nal

Document information

Uploaded on
October 19, 2025
Number of pages
25
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers

Subjects

Content preview

NR 546 / NR546 Final Exam – Psychopharmacology for PMHNP:
Complete 2025–2026 Study Guide with Real Exam Questions,
Verified Answers & Expert Rationales




Get fully prepared to ace your NR 546 / NR546 Psychopharmacology for PMHNP Final
Exam with this most comprehensive, up-to-date 2025–2026 exam review.

This expertly designed guide brings together real verified exam questions, accurate answers,
and in-depth rationales that mirror the current NR 546 test blueprint. Developed for
Psychiatric-Mental Health Nurse Practitioner (PMHNP) students, it covers every key topic—
from antidepressants and antipsychotics to neurotransmitter systems, mood stabilizers,
anxiolytics, and clinical psychopharmacology principle




1. Which neurotransmitter is most directly involved in the therapeutic effect of SSRIs?

A. Dopamine
B. Serotonin
C. Norepinephrine
D. Acetylcholine
✅ Answer: B. Serotonin
Explanation: SSRIs block serotonin reuptake transporters, increasing serotonin availability in the
synaptic cleft.



2. Which antidepressant is most likely to cause hypertension at high doses?

A. Bupropion
B. Paroxetine
C. Venlafaxine
D. Sertraline
✅ Answer: C. Venlafaxine
Explanation: Venlafaxine inhibits norepinephrine reuptake at higher doses, increasing BP.



3. A patient on clozapine develops fever, sore throat, and malaise. What is the priority lab?

,A. Serum lithium
B. CBC with differential
C. LFTs
D. Renal panel
✅ Answer: B. CBC with differential
Explanation: Agranulocytosis is a life-threatening side effect of clozapine; WBC and ANC must be
monitored.



4. The therapeutic plasma range for lithium is:

A. 0.2–0.6 mEq/L
B. 0.6–1.2 mEq/L
C. 1.5–2.0 mEq/L
D. 2.0–3.0 mEq/L
✅ Answer: B. 0.6–1.2 mEq/L
Explanation: Levels >1.5 mEq/L risk toxicity (tremor, confusion, seizures).



5. Which benzodiazepine has the shortest half-life?

A. Lorazepam
B. Alprazolam
C. Diazepam
D. Clonazepam
✅ Answer: B. Alprazolam
Explanation: Alprazolam’s short half-life contributes to rebound anxiety between doses.



6. Which medication can cause Stevens–Johnson syndrome?

A. Lamotrigine
B. Lithium
C. Valproate
D. Gabapentin
✅ Answer: A. Lamotrigine
Explanation: Rapid titration increases SJS risk; start low and titrate slowly.



7. Which antidepressant is contraindicated in patients with a seizure disorder?

A. Fluoxetine
B. Bupropion
C. Mirtazapine
D. Duloxetine

, ✅ Answer: B. Bupropion
Explanation: Bupropion lowers the seizure threshold.



8. The mechanism of action of buspirone involves partial agonism at which receptor?

A. 5-HT₁A
B. D₂
C. GABA-A
D. NMDA
✅ Answer: A. 5-HT₁A
Explanation: Buspirone is a serotonin 1A partial agonist used for generalized anxiety.



9. Which SSRI has the longest half-life?

A. Sertraline
B. Citalopram
C. Paroxetine
D. Fluoxetine
✅ Answer: D. Fluoxetine
Explanation: Fluoxetine’s long half-life (and active metabolite norfluoxetine) allows weekly dosing in
some cases.



10. Which of the following antipsychotics has the highest risk for metabolic syndrome?

A. Risperidone
B. Haloperidol
C. Aripiprazole
D. Olanzapine
✅ Answer: D. Olanzapine
Explanation: Olanzapine and clozapine are most strongly linked to weight gain and insulin resistance.



11. Which of the following drugs is an NMDA receptor antagonist used for dementia?

A. Donepezil
B. Rivastigmine
C. Memantine
D. Galantamine
✅ Answer: C. Memantine
Explanation: Memantine blocks NMDA glutamate receptors to prevent excitotoxicity in Alzheimer’s
disease.
R427,60
Get access to the full document:

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached


Document also available in package deal

Get to know the seller

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
studyguidepro NURSING
Follow You need to be logged in order to follow users or courses
Sold
72
Member since
4 months
Number of followers
4
Documents
1515
Last sold
22 hours ago
verified exams

Updated exams .Actual tests 100% verified.ATI,NURSING,PMHNP,TNCC,USMLE,ACLS,WGU AND ALL EXAMS guaranteed success.Here, you will find everything you need in NURSING EXAMS AND TESTBANKS.Contact us, to fetch it for you in minutes if we do not have it in this shop.BUY WITHOUT DOUBT!!!!Always leave a review after purchasing any document so as to make sure our customers are 100% satisfied. **Ace Your Exams with Confidence!**

3,9

18 reviews

5
10
4
1
3
4
2
1
1
2

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their exams and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can immediately select a different document that better matches what you need.

Pay how you prefer, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card or EFT and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Frequently asked questions